XML 20 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Operating activities    
Net loss $ (331,152) $ (153,331)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 8,259 6,215
Expensed in-process research and development 35,604  
Premium amortization and discount accretion on investment securities 5,707 3,333
(Gain) loss on investments (58)  
Stock-based compensation 84,797 34,406
Non-cash lease expense 8,106 5,819
Amortization of debt discount and issuance cost 917 149
Inventory reserve adjustments 726 (180)
Other non-cash benefits (charges) 133 (135)
Provision for credit losses 380 1,445
Loss on Debt Extinguishment   5,848
Accretion of Convertible Note   4,514
Changes in operating assets and liabilities    
Accounts receivable (32,232) (17,940)
Inventory (8,717) (7,803)
Prepaid expenses and other current assets (7,851) (7,288)
Other assets (550) 97
Accounts payable 183 (1,613)
Accrued compensation 4,960 6,362
Other accrued liabilities 34,845 16,362
Deferred revenue (40,557) (5,470)
Cash used in operating activities (236,500) (109,210)
Investing activities    
Purchases of investments (674,372) (479,037)
Proceeds from sale of investments 77,563 11,500
Proceeds from maturity of investments 348,410 247,315
Purchases of property and equipment, net (32,027) (12,073)
Cash paid for acquisition of an asset (4,271)  
Cash used in investing activities (284,697) (232,295)
Financing activities    
Proceeds from exercise of stock options 10,774 15,782
Proceeds from issuance of common stock under employee stock purchase plan 6,085 3,062
Proceeds from Convertible Note, net of issuance costs   278,316
Loan payment   (78,757)
Proceeds from public offering, net of issuance costs 550,814 270,650
Cash provided by financing activities 567,673 489,053
Net increase in cash, cash equivalents and restricted cash 46,476 147,548
Cash, cash equivalents and restricted cash, beginning of period 48,855 61,981
Cash, cash equivalents and restricted cash, end of period 95,331 209,529
Supplemental disclosure of cash flow information:    
Cash paid for interest 3,690 3,137
Non-cash investing and financing activities:    
Purchases of property and equipment in accounts payable and accruals $ 4,957 $ 2,814